Skip to main content
SpringerLink
Log in

Radionuclide Imaging in Thyroid Cancer

  • Chapter
  • First Online:
PET/CT in Thyroid Cancer

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 633 Accesses

Abstract

Please confirm if the author affiliation is correct.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, et al. Thyroid nodule shape suggests malignancy. Eur J Endocrinol. 2006;155:27–31.

    Article  CAS  PubMed  Google Scholar 

  2. Ezzal S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: Prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1338–40.

    Google Scholar 

  3. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1995;181:683–7.

    Article  Google Scholar 

  4. Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA. Sonographic features of benign thyroid nodules. J Ultrasound Med. 2003;22:1027–31.

    Article  PubMed  Google Scholar 

  5. Hay ID, Grant CS, Van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1994;112:1139–47.

    Google Scholar 

  6. Tourniaire J, Bernard MH, Bizzolon-Roblin MH, Bertholon-Gregoire M, Berger-Dutrieux N. 1998 Papillary microcarcinoma of the thyroid. 179 cases reported since. Presse Med. 1973;27:1467–9.

    Google Scholar 

  7. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccagna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-doppler features. J Clin Endocrinol Metabol. 2002;87:1941–6.

    Article  CAS  Google Scholar 

  8. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.

    Article  CAS  PubMed  Google Scholar 

  9. Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.

    Article  PubMed  Google Scholar 

  10. Sarkar SD, Becker DV. Thyroid uptake and imaging. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: JB Lippincott; 1995. p. 307–13.

    Google Scholar 

  11. Shulkin BL, Shapiro B. The role of imaging tests in the diagnosis of thyroid carcinoma. Endocrinol Metab Clin North Am. 1990;19:523–41.

    CAS  PubMed  Google Scholar 

  12. Charles MD. Thyroid and whole body imaging. In: Ingbar SH, Braverman LE, editors. The thyroid. 5th ed. Philadelphia: Lippincott; 1986. p. 458–78.

    Google Scholar 

  13. Robbins RJ, et al. The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 2005;46:28S–37S.

    CAS  PubMed  Google Scholar 

  14. Price DC. Radioisotopic evaluation of the thyroid and the parathyroids. Radiol Clin North Am. 1993;31:991–1015.

    CAS  PubMed  Google Scholar 

  15. Kusic Z, et al. Comparison of technetium-99m and iodine-123 imaging of thyroid nodules: Correlation with pathologic findings. J Nucl Med. 1990;31:393–9.

    CAS  PubMed  Google Scholar 

  16. Intenzo CM, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003;23:857–69.

    Article  PubMed  Google Scholar 

  17. Freitas JE, Freitas AE. Thyroid and parathyroid imaging. Semin Nucl Med. 1994;24:234–45.

    Article  CAS  PubMed  Google Scholar 

  18. Belfiore A, et al. Cancer risk in patients with cold thyroid nodules: Relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93:363–9.

    Article  CAS  PubMed  Google Scholar 

  19. Van Nostrand D, et al. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET. J Nucl Med. 2012;53:359–62.

    Article  PubMed  Google Scholar 

  20. Mazzaferri EI. Empirically treating high serum thyroglobulin levels. J Nucl Med. 2005;46:1079–88.

    PubMed  Google Scholar 

  21. Spanu A, et al. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med. 2009;50:184–90.

    Article  PubMed  Google Scholar 

  22. Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, et al. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31(10):1435–42.

    Article  CAS  PubMed  Google Scholar 

  23. Delbeke D, Schoder H, Martin WH, Wahl RL. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med. 2009;39(5):308–40.

    Article  PubMed  Google Scholar 

  24. Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med. 1998;39(9):1542–6.

    CAS  PubMed  Google Scholar 

  25. Lind P, Kohlfurst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36(3):194–205.

    Article  PubMed  Google Scholar 

  26. Van Sorge-van Boxtel RA, van Eck-Smit BL, Goslings BM. Comparison of serum thyroglobulin, 131I and 201Tl scintigraphy in the postoperative follow-up of differentiated thyroid cancer. Nucl Med Commun. 1993;14(5):365–72.

    Article  PubMed  Google Scholar 

  27. Wong KK, et al. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT. AJR Am J Roentgenol. 2010;195:730–6.

    Article  PubMed  Google Scholar 

  28. Schmidt D, et al. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J Nucl Med. 2009;50:18–23.

    Article  PubMed  Google Scholar 

  29. Avram AM. Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification. J Nucl Med. 2012;53:754–64.

    Article  PubMed  Google Scholar 

  30. Maruoka Y, et al. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma. Radiology. 2012;265:902–9.

    Article  PubMed  Google Scholar 

  31. Buck AK, Nekolla SG, Ziegler SI, Drzezga A. SPECT/CT. J Nucl Med. 2008;49(8):1305–19.

    Article  PubMed  Google Scholar 

  32. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009 Nov;19(11):1167–214.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UK

    Emmanouil Panagiotidis

Authors
  1. Emmanouil Panagiotidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmanouil Panagiotidis .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom

    Sobhan Vinjamuri

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Panagiotidis, E. (2018). Radionuclide Imaging in Thyroid Cancer. In: Vinjamuri, S. (eds) PET/CT in Thyroid Cancer. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-71846-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71846-0_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71845-3

  • Online ISBN: 978-3-319-71846-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation